Treatments involve correcting the leukocytopenia and thrombocytopenia by transfusion of blood or specific hematocytes and stimulating synthesis of homogeneous blood cells using the traditional (filgrastim) or pegylated (pegfilgrastim) granulocyte colony-stimulating factor (G-CSF), or the granulocyte-macrophage colony-stimulating factor (GM-CSF) or sargramostim. The gene discussed is CSF3; the disease is Thrombocytopenia.